These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 26925194)
21. In vivo evidence that the increase in matrix metalloproteinase activity occurs early after cerebral ischemia. Martín A; Garofalakis A; Tavitian B Mol Imaging; 2012 Feb; 11(1):22-6. PubMed ID: 22418024 [TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases and free radicals in cerebral ischemia. Jian Liu K; Rosenberg GA Free Radic Biol Med; 2005 Jul; 39(1):71-80. PubMed ID: 15925279 [TBL] [Abstract][Full Text] [Related]
23. MMPs: a novel drug target for schizophrenia. Chopra K; Baveja A; Kuhad A Expert Opin Ther Targets; 2015 Jan; 19(1):77-85. PubMed ID: 25214056 [TBL] [Abstract][Full Text] [Related]
25. Optimal level activity of matrix metalloproteinases is critical for adult visual plasticity in the healthy and stroke-affected brain. Pielecka-Fortuna J; Kalogeraki E; Fortuna MG; Löwel S Elife; 2015 Nov; 5():e11290. PubMed ID: 26609811 [TBL] [Abstract][Full Text] [Related]
26. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Cauwe B; Opdenakker G Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):351-423. PubMed ID: 20812779 [TBL] [Abstract][Full Text] [Related]
27. Matrix metaloproteinases activity during the evolution of hypoxic-ischemic brain damage in the immature rat. The effect of 1-methylnicotinamide (MNA). Dragun P; Makarewicz D; Wójcik L; Ziemka-Nałecz M; Słomka M; Zalewska T J Physiol Pharmacol; 2008 Sep; 59(3):441-55. PubMed ID: 18953089 [TBL] [Abstract][Full Text] [Related]
28. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439 [TBL] [Abstract][Full Text] [Related]
29. The role of iron neurotoxicity in ischemic stroke. Selim MH; Ratan RR Ageing Res Rev; 2004 Jul; 3(3):345-53. PubMed ID: 15231241 [TBL] [Abstract][Full Text] [Related]
30. Neuron-Specific Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke. Gong J; Li ZZ; Guo S; Zhang XJ; Zhang P; Zhao GN; Gao L; Zhang Y; Zheng A; Zhang XF; Xiang M; Li H Hypertension; 2015 Sep; 66(3):604-16. PubMed ID: 26269654 [TBL] [Abstract][Full Text] [Related]
31. Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice. Copin JC; Goodyear MC; Gidday JM; Shah AR; Gascon E; Dayer A; Morel DM; Gasche Y Eur J Neurosci; 2005 Oct; 22(7):1597-608. PubMed ID: 16197500 [TBL] [Abstract][Full Text] [Related]
32. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Gu Z; Kaul M; Yan B; Kridel SJ; Cui J; Strongin A; Smith JW; Liddington RC; Lipton SA Science; 2002 Aug; 297(5584):1186-90. PubMed ID: 12183632 [TBL] [Abstract][Full Text] [Related]
33. Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats. Jang JW; Lee JK; Hur H; Kim TW; Joo SP; Piao MS J Neurol Sci; 2014 Apr; 339(1-2):75-80. PubMed ID: 24507948 [TBL] [Abstract][Full Text] [Related]
34. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke. Frankowski JC; DeMars KM; Ahmad AS; Hawkins KE; Yang C; Leclerc JL; Doré S; Candelario-Jalil E Sci Rep; 2015 Dec; 5():17956. PubMed ID: 26648273 [TBL] [Abstract][Full Text] [Related]
35. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke. Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272 [TBL] [Abstract][Full Text] [Related]
36. Micro-RNA-30a regulates ischemia-induced cell death by targeting heat shock protein HSPA5 in primary cultured cortical neurons and mouse brain after stroke. Wang P; Zhang N; Liang J; Li J; Han S; Li J J Neurosci Res; 2015 Nov; 93(11):1756-68. PubMed ID: 26301516 [TBL] [Abstract][Full Text] [Related]
37. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. Gharibani PM; Modi J; Pan C; Menzie J; Ma Z; Chen PC; Tao R; Prentice H; Wu JY Adv Exp Med Biol; 2013; 776():241-58. PubMed ID: 23392887 [TBL] [Abstract][Full Text] [Related]
38. Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. Lee JE; Yoon YJ; Moseley ME; Yenari MA J Neurosurg; 2005 Aug; 103(2):289-97. PubMed ID: 16175859 [TBL] [Abstract][Full Text] [Related]
39. Matrix Metalloproteinases in Cardioembolic Stroke: From Background to Complications. Wysocka A; Szczygielski J; Kopańska M; Oertel JM; Głowniak A Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835040 [TBL] [Abstract][Full Text] [Related]
40. Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion. Amantea D; Corasaniti MT; Mercuri NB; Bernardi G; Bagetta G Neuroscience; 2008 Mar; 152(1):8-17. PubMed ID: 18255236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]